Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebocontrolled, adaptive phase 3 study - Bril, V; Druzdz, A; Grosskreutz, J (Lancet Neurol, 2023)